← SynDRA
LYS006
SynDRA canonical compound SYN1970224 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | LTA4H |
| Mechanism of action | leukotriene inhibitor |
| Indication | inflammatory bowel disease |
| Disease area | gastroenterology |
All known targets
Mechanisms of action (all sources)
- leukotriene inhibitor
- LTA4H INHIBITOR
Cross-references
Synonyms
- (3~{S})-3-azanyl-4-[5-[4-(5-chloranyl-3-fluoranyl-pyridin-2-yl)oxyphenyl]-1,2,3,4-tetrazol-2-yl]butanoic acid
- (3S)-3-amino-4-[5-[4-(5-chloro-3-fluoropyridin-2-yl)oxyphenyl]tetrazol-2-yl]butanoic acid
- (S)-3-amino-4-(5-(4-((5-chloro-3-fluoropyridin-2-yl)oxy)phenyl)-2H-tetrazol-2-yl)butanoic acid
- 2H-TETRAZOLE-2-BUTANOIC ACID, .BETA.-AMINO-5-(4-((5-CHLORO-3-FLUORO-2-PYRIDINYL)OXY)PHENYL)-, (.BETA.S)-
- 2H-Tetrazole-2-butanoic acid, beta-amino-5-(4-((5-chloro-3-fluoro-2-pyridinyl)oxy)phenyl)-, (betaS)-
- 59CF90960T
- BDBM50575488
- betaS-amino-5-[4-[(5-chloro-3-fluoro-2-pyridinyl)oxy]phenyl]-2H-tetrazole-2-butanoic acid
- CHEMBL4852381
- CS-0137600
- EX-A4286
- GTPL11205
- HY-137298
- LTA4H-IN-1
- LYS-006
- MS-26579
- RZE
- SCHEMBL16827313
- UNII-59CF90960T
- RefChem:154743
- C16H14ClFN6O3
- orb1685240
- SCHEMBL29648446
- CPD (S)-22
- GLXC-23677
- LYS-006?
- EBC-518451
- LYS-006; LYS 006; LYS006
- T9690
- G17571
Look up LYS006 in the interactive SynDRA portal →